Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 10, 2024
Reporting Period: Quarter ended March 31, 2024
Context: The Company issued a press release announcing preliminary financial results for the quarter ended March 31, 2024. This filing serves to disclose the issuance of that press release under Item 2.02.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release (Exhibit 99.1) containing these preliminary results but does not reproduce the data within the text of the 8-K itself.
Material Changes
The filing text does not provide specific data to compare against prior periods. It only confirms the announcement of preliminary results for the quarter ended March 31, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding preliminary results but does not include the content of management's commentary, guidance, or outlook within this text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 10, 2024) for the actual preliminary financial figures for the quarter ended March 31, 2024.
- Verify the specific revenue, net income, and cash flow numbers once the press release is accessed.
- Check for any forward-looking statements or guidance included in the attached press release.
- Confirm if the preliminary results differ significantly from prior expectations or analyst estimates.